Your browser doesn't support javascript.
loading
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.
Norton, Nadine; Fox, Nicholas; McCarl, Christie-Ann; Tenner, Kathleen S; Ballman, Karla; Erskine, Courtney L; Necela, Brian M; Northfelt, Donald; Tan, Winston W; Calfa, Carmen; Pegram, Mark; Colon-Otero, Gerardo; Perez, Edith A; Clynes, Raphael; Knutson, Keith L.
Afiliación
  • Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA.
  • Fox N; Department of Pathology, Medicine and Dermatology, Columbia University Medical Center, New York, NY, 10032, USA.
  • McCarl CA; Department of Pathology, Medicine and Dermatology, Columbia University Medical Center, New York, NY, 10032, USA.
  • Tenner KS; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
  • Ballman K; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA.
  • Erskine CL; Department of Immunology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Necela BM; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA.
  • Northfelt D; Department of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, 85259, USA.
  • Tan WW; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA.
  • Calfa C; Sylvester Cancer Center, University of Miami, Miami, FL, 33136, USA.
  • Pegram M; Department of Medicine, Stanford University, Stanford, CA, 94305, USA.
  • Colon-Otero G; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA.
  • Perez EA; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA. perez.edith@mayo.edu.
  • Clynes R; Department of Pathology, Medicine and Dermatology, Columbia University Medical Center, New York, NY, 10032, USA. rclynes@xencor.com.
  • Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, FL, 32224, USA. knutson.keith@mayo.edu.
Breast Cancer Res ; 20(1): 52, 2018 06 14.
Article en En | MEDLINE | ID: mdl-29898752
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Anticuerpos Monoclonales Humanizados / Trastuzumab / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Anticuerpos Monoclonales Humanizados / Trastuzumab / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido